Skip to main content Accessibility help
×
Hostname: page-component-77c89778f8-5wvtr Total loading time: 0 Render date: 2024-07-22T15:43:19.441Z Has data issue: false hasContentIssue false

Case 47 - Not Quite So Reserved Anymore

Published online by Cambridge University Press:  01 March 2019

Tom Solomon
Affiliation:
University of Liverpool
Benedict D. Michael
Affiliation:
Institute of Infection & Global Health, University of Liverpool
Alastair Miller
Affiliation:
Tropical & Infectious Disease Unit, Royal Liverpool Hospital
Rachel Kneen
Affiliation:
Alder Hey Children’s Hospital, Liverpool
Get access
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Major, EO, Amemiya, K, Tornatore, CS, Houff, SA, Berger, JR. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 1992;5:4973.CrossRefGoogle ScholarPubMed
Saribas, AS, Ozdemir, A, Lam, C, Safak, M. JC virus-induced progressive multifocal leukoencephalopathy. Future Virol 2010;5:313–23.CrossRefGoogle ScholarPubMed
Berger, JR. Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions. J Neurovirol 2003;9(Suppl 1):3841.CrossRefGoogle ScholarPubMed
Mateen, FJ, Muralidharan, R, Carone, M, et al. Progressive multifocal leukoencephalopathy in transplant recipients. Annals Neurol 2011;70:305–22.CrossRefGoogle ScholarPubMed
Yousry, TA, Major, EO, Ryschkewitsch, C, et al. Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 2006;354:924–33.CrossRefGoogle ScholarPubMed
Sorensen, PS, Bertolotto, A, Edan, G, et al. Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab. Mult Scler 2012;18:143–52.CrossRefGoogle ScholarPubMed
Hunt, D, Giovannoni, G. Natalizumab-associated progressive multifocal leucoencephalopathy: a practical approach to risk profiling and monitoring. Pract Neurol 2012;12:2535.CrossRefGoogle ScholarPubMed
Berger, JR, Aksamit, AJ, Clifford, DB, et al. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology 2013;80:1430–8.CrossRefGoogle ScholarPubMed
Gofton, TE, Al-Khotani, A, O’Farrell, B, Ang, LC, McLachlan, RS. Mefloquine in the treatment of progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psych 2011;82:452–5.Google Scholar
Brew, BJ, Davies, NW, Cinque, P, Clifford, DB, Nath, A. Progressive multifocal leukoencephalopathy and other forms of JC virus disease. Nature Rev Neurol 2010;6:667–79.CrossRefGoogle ScholarPubMed
Antinori, A, Cingolani, A, Lorenzini, P, et al. Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). J Neurovirol 2003;9(Suppl 1):4753.CrossRefGoogle ScholarPubMed
Steiner, I, Berger, JR. Update on progressive multifocal leukoencephalopathy. Curr Neurol Neurosci Rep 2012;12:680–6.CrossRefGoogle ScholarPubMed
Tan, CS, Koralnik, IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 2010;9:425–37.CrossRefGoogle ScholarPubMed
Padgett, BL, Walker, DL, ZuRhein, GM, Eckroade, RJ, Dessel, BH. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971;1:1257–60.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×